Amgen Inc. buy phonebroker
Start price
29.04.21
/
40%
€196.62
Target price
29.04.22
€217.00
Performance (%)
-3.11%
End price
23.08.21
€190.50
Summary
This prediction ended on 23.08.21 with a price of €190.50. With a performance of -3.11%, the BUY prediction for Amgen Inc. by phonebroker closed slightly in the red. Dividends of €2.95 are taken into consideration when calculating the performance. phonebroker has 40% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | 0.852% | 0.852% | 23.811% | 32.974% |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% | 53.202% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% | 91.095% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% | 63.933% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% | 64.840% |
Comments by phonebroker for this prediction
In the thread Amgen Inc. diskutieren
Buy Amgen Inc.
Kursziel gesetzt auf 217,0